Semler Scientific (OTCMKTS:SMLR – Get Rating) issued its quarterly earnings results on Monday. The medical equipment provider reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.48 by ($0.07), MarketWatch Earnings reports. Semler Scientific had a net margin of 32.48% and a return on equity of 44.76%.
OTCMKTS SMLR opened at $47.34 on Tuesday. The stock’s 50 day moving average is $50.02 and its two-hundred day moving average is $79.62. The company has a market capitalization of $320.02 million, a price-to-earnings ratio of 20.26 and a beta of 0.90. Semler Scientific has a 1-year low of $41.53 and a 1-year high of $153.21.
In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 2,000 shares of Semler Scientific stock in a transaction that occurred on Monday, February 28th. The stock was sold at an average price of $72.65, for a total transaction of $145,300.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 13.20% of the stock is currently owned by insiders.
Several equities research analysts have recently issued reports on the company. Colliers Securities reaffirmed a “buy” rating on shares of Semler Scientific in a research report on Tuesday, March 22nd. Zacks Investment Research raised Semler Scientific from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 24th. B. Riley decreased their target price on Semler Scientific from $145.00 to $70.00 and set a “buy” rating on the stock in a research report on Monday, March 7th. TheStreet downgraded Semler Scientific from a “b-” rating to a “c” rating in a report on Thursday, March 3rd. Finally, Lake Street Capital decreased their price objective on Semler Scientific from $175.00 to $100.00 in a report on Tuesday, March 1st. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $120.25.
Semler Scientific Company Profile (Get Rating)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- MarketBeat Podcast: Investing In Innovation, Robotics, AI and Healthcare
- It’s Time to Book an Appointment for Teladoc Stock
- GitLab Stock is Trying to Put in a Bottom Here
- Saia Growth Accelerates But It May Not Matter
- onsemi Is A Deep-Value In The Chip Sector
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.